Balance Sheet Data
Arrowhead Pharmaceuticals, Inc. (ARWR)
$23.95
-0.58 (-2.36%)
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Actual | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected | 2028 Projected |
| Total Cash | 258.70 | 315.49 | 367.79 | 376.40 | 110.89 | 570.28 | 690.25 | 835.46 | 1,011.22 | 1,223.96 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.66 | 0.85 | 10.26 | 1.41 | 5.63 | 6.81 | 8.24 | 9.98 | 12.08 | 14.62 |
| Account Receivables (%) | ||||||||||
| Inventories | 3.32 | 4.25 | 4.36 | -21.61 | 0.64 | 0.78 | 0.94 | 1.14 | 1.38 | 1.66 |
| Inventories (%) | ||||||||||
| Accounts Payable | 7.65 | 6.83 | 9.46 | 2.87 | 35.87 | 20.52 | 24.84 | 30.06 | 36.38 | 44.04 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -12 | -11.95 | -23.57 | -52.78 | -176.74 | -77.42 | -93.71 | -113.42 | -137.28 | -166.16 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.